94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Pedro Nogueira Fontana1,2*
Vinícius Gomes da Silva1
Roseli Corazzini1Natália Merten Athayde1
Ana Marina Dutra Ferreira da Silva1Igor Brockhausen1
Carolina da Cunha Correia2
Cláudia Ferreira da Rosa Sobreira3
Pedro José Tomaselli3Flávio Petean3
Rodrigo de Oliveira3
Pablo Vinícius Feitoza4
Michel Moraes Soane5Natália Saraiva5
Rafaela Hidalgo5Cláudia Fideles5
David Feder1
Alzira Alves de Siqueira Carvalho1*- 1Neurosciences and Clinical Department, Centro Universitário ABC, Santo André, Brazil
- 2Faculty of Medical Sciences, Universidade de Pernambuco, Recife, Brazil
- 3Department of Neurosciences and Behavioral Sciences, Universidade de São Paulo - Ribeirão Preto, São Paulo, Brazil
- 4Department of Clinical Surgery, Faculty of Medicine, Universidade Federal do Amazonas, Manaus, Brazil
- 5EUROIMMUN Brazil, São Caetano do Sul, Brazil
A corrigendum on
Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
by Fontana, P. N., da Silva, V. G., Corazzini, R., Athayde, N. M., Ferreira da Silva, A. M. D., Brockhausen, I., Correia, C. d. C., Sobreira, C. F. d. R., Tomaselli, P. J., Petean, F., de Oliveira, R., Feitoza, P. V., Moraes Soane, M., Saraiva, N., Hidalgo, R., Fideles, C., Feder, D., and Carvalho, A. A. d. S. (2025). Front. Neurol. 15:1504260. doi: 10.3389/fneur.2024.1504260
In the published article, an author name was incorrectly written as Pedro Tomaselli. The correct spelling is Pedro José Tomaselli.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: idiopathic inflammatory myopathies, myositis-specific antibodies, muscle biopsy, dermatomyositis, immune-mediated necrotizing myopathy, anti-synthetase syndrome, inclusion body myositis, myositis-associated antibodies
Citation: Fontana PN, da Silva VG, Corazzini R, Athayde NM, Ferreira da Silva AMD, Brockhausen I, Correia CdC, Sobreira CFdR, Tomaselli PJ, Petean F, de Oliveira R, Feitoza PV, Moraes Soane M, Saraiva N, Hidalgo R, Fideles C, Feder D and Carvalho AAdS (2025) Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all. Front. Neurol. 16:1567315. doi: 10.3389/fneur.2025.1567315
Received: 27 January 2025; Accepted: 28 January 2025;
Published: 12 February 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Fontana, da Silva, Corazzini, Athayde, Ferreira da Silva, Brockhausen, Correia, Sobreira, Tomaselli, Petean, de Oliveira, Feitoza, Moraes Soane, Saraiva, Hidalgo, Fideles, Feder and Carvalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pedro Nogueira Fontana, cGVkcm9ub2d1ZWlyYWZvbnRhbmFAZ21haWwuY29t; Alzira Alves de Siqueira Carvalho, YWx6aXJhc2lxdWVpcmFjYXJ2YWxob0BnbWFpbC5jb20=